Prof. dr Milan Apostolović

orthopedic surgeon

Education:

1983 Undergraduate studies, Faculty of Medicine, University of Belgrade
1992 Specialization, Faculty of Medicine, University of Belgrade
1996 Master of Medical Sciences, Faculty of Medicine, University of Belgrade
2010 PhD in Medical Sciences, Faculty of Medicine, University of Belgrade
2019 Professor, Faculty of Medicine, University of Belgrade

Work experience:

Institute for Orthopedic and Surgical Diseases, Banjica
Associate Professor at the Department of Surgery, Faculty of Medicine, University of Belgrade

Memberships:

Serbian Medical Association, Medical Chamber of Serbia

Surgeons

Dr sci. med. Vojislav Bogosavljević

Prof. dr sci. med. Otaš Durutović

urolog

Education:

1996 Faculty of Medicine, University of Belgrade
2004 Specialization in urology
2007 Master’s thesis in the field of male infertility
2016 Doctorate in the field of minimally invasive treatment of complex kidney calculus

Work experience:

from 1998 Employed at the Urology Clinic of the University Clinical Center of Serbia, head of the calculus department
from 2022 Professor of Surgery with Anesthesiology, Urology, Faculty of Medicine, University of Belgrade

Memberships and professional training:

He is a member of the Serbian Medical Society, Serbian and European Association of Urologists

Since 2018 he is an educator at European School of Urology for minimally invasive techniques for the treatment of calculus in urinary tract

He is the winner of several first prizes for presentations at European urological meetings

Education in the field of minimally invasive endourological techniques at the University AKH Clinic in Vienna with Prof. Dr. Michael Marberger (2010), in Innsbruck with Prof. Udo Nagele (2015), in Paris with Prof. Olivier Traxer.(2017)

He has introduced several minimally invasive techniques in the field of kidney and urinary tract calculus treatment at the University Clinical Center of Serbia, including PCNL (percutaneous nephrolitholapaxy) and FURS (flexible laser lithotripsy)

Areas of interest:

Minimally invasive and laser techniques in the treatment of urological diseases, Endourology

Urologists

Dr sci. med. Milutin Kozomara

Ass. dr sci. med. Milan Radovanović

Ass. dr Veljko Šantrić

Prof. dr Mirjana Gotić

hematologist

Education:

1977-1983 Doctor of Medicine, Faculty of Medicine, University of Belgrade
1984-1988 Postgraduate studies in Hematology, Faculty of Medicine, University of Belgrade
1990 Academic Hematology and Cytogentics, Royal Marsden Hospital, London, (Head Prof. Dr. Daniel Catovsky), Scholarship of the Ministry of Science, Republic of Serbia
1988 – 1992 Specialization in Internal Medicine, Institute of Hematology, University Clinical Center, Belgrade

Academic career:

1989 Master of Medical Sciences (Mr sci med), Faculty of Medicine, University of Belgrade
1991-1999 Assistant at the Department of Internal Medicine, n.b. Department of Hematology, Faculty of Medicine, University of Belgrade
June 1998 Doctor of Medical Sciences (Dr sci med), Faculty of Medicine, University of Belgrade
1999-2004 Docent at the Department of Internal Medicine, n.b. Department of Hematology, Faculty of Medicine, University of Belgrade
2004–2011 Associate Professor at the Department of Internal Medicine, n.b. Hematology Clinic, Faculty of Medicine, University of Belgrade
from 2011 Professor at the Department of Internal Medicine, n.b. Clinical Professor of Hematology, Faculty of Medicine, University of Belgrade

Work experience:

1986 – 1992 Doctor of Medicine, Institute of Hematology, University Clinical Center, Belgrade
1992 – 2024 Specialist in Internal Medicine, Institute (Clinic) of Hematology, Clinical Center of Serbia, Belgrade
2008 – 2024 Subspecialist in Hematology, Clinic of Hematology, Clinical Center of Serbia, Belgrade
2001- 2022 Head of the Polyclinic-Diagnostic Department of the Hematology Clinic of the Clinical Center of Serbia, Belgrade
2022 – 2024 Head of the Department for Myeloproliferative Neoplasms of the Hematology Clinic of the University Clinical Center of Serbia in Belgrade

Memberships:

since 1983 Member of the Serbian Medical Association
Member of the European Hematology Association since 1994
2002 – 2005 Member of the editorial board of “The Journal of the Hellenic Society of Haematology”
since 2009 Member of the Central European Myeloproliferative Study Organization (CEMPO)
since 2011 Member of the Editorial Board of the magazine “Serbian Archive for the entire medicine of SLD”
2011-2014 President of the Hematology Section of the SLD
2016-2022 Associate member of the Academy of Medical Sciences of the Serbian Medical Association
from 2022 Regular member of the Academy of Medical Sciences of the Serbian Medical Association

National research projects:

2002-2005 MNTR project, no. 1682, entitled: “Molecular-biological detection of minimal residual disease in chronic lymphoid leukemias and its impact on patient survival”, Project leader Prof. Dr. Mirjana Gotić

2006 – 2010 Project MNTR, no. 145048, under the title: “Cellular and molecular mechanisms of hematopoiesis regulation” Project leader Prof. Dr. Pavle Milenković, Associate Researcher Prof. Dr. Mirjana Gotić

2011 – 2022 Project MNTR, no. 175053, under the title: “Investigation of the pathogenesis of hematological malignancies”, Project leader Scientific associate Dr. sci med Vladan Čokić, Ph.D. Research associate Prof. Dr. Mirjana Goti

International research projects and studies:

1992-1997 „An open protocol for the use of Agrelin (Anagrelide) for patients with thrombocythemia“, Project No 282, Protocol No 292-024 COINVESTIGATOR

1989-1992 „Pentostatin in Patients with Active Hairy Cell Leukemia Previously Treated with Interferon Alpha” Protocol No 188-0015, Group C Treatment Protocol, COINVESTIGATOR

2003-2003 „SPD422-306 ANAGRELIDE RETROSPECTIVE DATA COLLECTION STUDY“, PRINCIPLE INVESTIGATOR

2003-2005 „A phase III study to evaluate the efficacy and safety of front line therapy with alemtuzumab (Campath, MabCampath) vs chlorambucil in patients with progressive B-cell chronic lymphocytic leukaemia, CAM307“, INVESTIGATOR

2005-2007 „A single blind, multi-centre, randomised multinational Phase III Study to compare the efficacy and tolerability of Anagrelide vs Hydroxyurea in patients with essential thrombocythemia, ANAHYDRET², PRINCIPLE INVESTIGATOR

2006-2007 Study group Indolent Lymphomas: “Therapy Optimization Study for the Treatment of Hairy Cell Leukemia, Subcutaneous Use of Cladribine in Hairy Cell Leukemia”, INVESTIGATOR

2007-2008 “A Phase II, open-label, multicentre, pharmacokinetic, pharmacodynamics and safety study of anagrelide hydrochloride in young (18-50 years) and elderly (³ 65 years) patients with essential thrombocythaemia, SPD422-203“, PRINCIPLE INVESTIGATOR

2007- 2008 “A Phase II trial to evaluate the efficacy and safety of subcutaneously administered alemtuzumab (CAMPATHâ, MabCampathâ) in patients with previously treated B-cell Chronic Lymphocytic Leukaemia, CAM203“, INVESTIGATOR

2007 – 2010 “A Phase IIIb, randomised, open label study to compare the safety, efficacy and tolerability of anagrelide hydrochloride versus hydroxyurea in high-risk essential thrombocythaemia patients, SPD422-403“, PRINCIPLE INVESTIGATOR for Serbia

2009 – 2016 COORDINATING PRINCIPLE INVESTIGATOR for European Union and Eastern Europe

2012 – 2014 „A Randomized, Open-label, Phase 3 Study of Carfilzomib vs Best Supportive Care in Subjects with Relapsed and Refractory Multiple Myeloma, PX-171-011“, PRINCIPLE INVESTIGATOR

2016 -2017 ‘A Pivotal Multicenter Trial of Moxetumomab Pasudotox in Relapsed/Refractory Hairy Cell Leukemia, CD-ON-CAT-8015-1053“, PRINCIPLE INVESTIGATOR

From 2021 “A Randomized Controlled Phase 3 Study of Pacritinib Versus Physician¢s Choice on Patients with Primary Myelofibrosis, Post Polycythemia Vera Myelofibrosis, or Post Essential Thrombocythemia Myelofibrosis with Severe Thrombocytopenia (Platelet Counts <50,000/mL), PACIFICA, PAC303“, PRINCIPLE INVESTIGATOR

2021-2023 „An Open –Label, Multicenter, Phase 1b/2 Study of the Safety and Efficacy of KRT-232 with TL-895 in Subjects with Relapsed/Refractory Myelofibrosis and KRT-232 in Janus-associated Kinase Inhibitor-Intolerant Myelofibrosis, KRT-232-113“, PRINCIPLE INVESTIGATOR

Awards and publications:

2018 Award for scientific and research work of the Serbian Medical Society

Number of presented and published works: > 400

(90 papers “in extenso” in the Pub Med database)

Number of citations (Google Academic): 1707

h-index: 19

Hematologists

Asist. dr Olivera Tamaš

neurologist

Education:

2004. Basic studies, Faculty of Medicine, University of Novi Sad
2010. Master studies – Faculty of Medicine in Novi Sad, mentor: prof. Dr. Maria Zharkov
2011. Professional training within the EU IPA project RISAIND. Biological Research Center, Szeged, mentor: prof. Dr. Halaczky Gyula, Szeged, Hungary.
2013. Professional study within the EU IPA project MULTSCLER Clinic of Neurology, University of Szeged, Department of Immune-Mediated Diseases of the Central Nervous System, mentor: prof. Dr. Laszlo Vecsei, Szeged, Hungary
2014. Specialization in Neurology – Faculty of Medicine, University of Belgrade
2018 – 2023. Training in the most prominent Multiple Sclerosis treatment centers: Multiple Sclerosis Perceptorship, Innsbruck, 2018. mentor: Thomas Berger, Multiple Sclerosis Perceptorship, Vienna, 2019. mentor: Thomas Berger, Multiple Sclerosis Perceptorship, Barcelona, 2020. mentor: Xavier Montalban, Multiple Sclerosis Perceptorship, Dresden, 2023. mentor: Tjalf Ziemssen
2024. Doctoral dissertation entitled “Morphological – clinical, neuropsychological and genetic correlations of degenerative cerebellar ataxias” as part of doctoral studies in the field of Neurology, mentor: Prof dr Vladimir S. Kostić, Faculty of Medicine, University of Belgrade

Work experience:

from 2010 to 2016 employed at the Department of Neurology at the Subotica General Hospital
since 2017 employed at the Department of Immune-Mediated Diseases of the Central Nervous System, Clinic of Neurology, UKCS
since 2020 clinical assistant at the Department of Neurology, Faculty of Medicine, University of Belgrade

Special interest:

Demyelinating and immune-mediated diseases of the central nervous system, multiple sclerosis (MS), cerebrospinal fluid examination, the role of magnetic resonance imaging in the diagnosis and monitoring of MS, neuroimaging in MS, modern principles of MS therapy and immunology, and clinical studies. In addition, the area of interest are other inflammatory demyelinating diseases of the central nervous system such as neuromyelitis optica spectrum disease (NMOSD), disease associated with antiMOG antibodies (MOGAD) and cerebellum disease.

Memberships:

Association of Neurologists of Serbia

European Academy of Neurologists

Serbian Medical Association

Medical Chamber of Serbia

Foreign languages:

English, German and Hungarian

Neurologists

Prof. dr Aleksandra Pavlović

Prof. dr Ljiljana Beslać-Bumbaširević

Prof. dr Ivana Basta

Prof. dr Elka Stefanova

Doc. dr Gorana Mandić – Stojmenović

Doc. dr Maja Milovanović

Prof. dr Radmila Ješić

hepatologist

Education:

1977 Doctor of Medicine, Faculty of Medicine in Belgrade
1979 Postgraduate studies in cardiology
1986 Specialization in Internal Medicine in Belgrade
1988 Doctorate with the topic “Determination of echographic markers of circumscribed liver lesions and assessment of reliability of echo image interpretation”
1990 Subspecialty in gastroenterology and hepatology

Work experience:

1983 Head of Hepatology II, Clinic for Gastroenterology and Hepatology, Clinical Center of Serbia
2008 Full professor at the Department of Internal Medicine, Faculty of Medicine, University of Belgrade

Publications:

She has published over 250 papers in international and national journals, books, conference proceedings and abstracts.

Professional memberships:

European Organization for Organ Transplantation, President of the Republican Commission for Liver Transplantation Association of Gastroenterologists of Serbia, Serbian Medical Association

Closer interests:

Hepatology, liver transplantation

Gastroenterologists

Prof. dr Snežana Lukić

Prof. dr Dragan Popović

Dr Ljubiša Tončev

Dr Milan Špuran

Dr Radmilo Krstić

Dr Daniela Folić

general practitioner

Education:

2012-2015 Medical Lyceum No. 1535, Moscow, Russian Federation
2015-2022 Faculty of Medicine, University of Belgrade
from 2023 resident doctor in the field of radiology at the Medical Faculty of the University of Belgrade

Work experience:

from 2023 general practitioner, resident doctor in radiology, Ars Medica Beograd

Languages:

Russian, Serbian, English

General practitioners

Dr Natalija Ajdačić

Dr Jelena Jovanović

Ass. dr sci. med. Marijana Milović-Kovačević

oncologist

Education:

1997 she graduated from basic studies, Faculty of Medicine, University of Belgrade
2004 Master’s degree at the Faculty of Medicine, University of Belgrade (“Monitoring of the nephrotoxic effect of various aminoglycosides during febrile neutropenia caused by cytotoxic therapy”)
2005 specialization in Internal Medicine, Faculty of Medicine, University of Belgrade
2010 she received her doctorate at the Faculty of Medicine of the University of Belgrade (“Effect of ERCC1 protein expression level on resistance to platinum regimens in ovarian cancer”)
2015 subspecialization in oncology, Faculty of Medicine, University of Belgrade

Work experience:

Since 1999, medical oncologist, Institute of Oncology and Radiology of Serbia, Clinic for Medical Oncology, Department of Breast Cancer and Gynecology

Oncologists

Prim. dr sci. med. Davorin Radosavljević

Dr sci. med. Ivana Božović Spasojević

Spec. dr med. Feđa Đorđević

Dr med. Miodrag Jašović

Dr sci. med. Ivana Božović Spasojević

oncologist

Dr Božović-Spasojević is a specialist in Internal Medicine, a subspecialist in Clinical Oncology, a Senior Research Associate in the field of oncology and a clinical assistant at the Faculty of Medicine in Belgrade in the subject Clinical Oncology and Radiotherapy. She completed the breast cancer subspecialization program at the ULM University in Germany under the support of the European School of Oncology (ESO).

She is a regular member of the council for the treatment of breast cancer and malignancy of gynecological organs at the Institute of Oncology and Radiology of Serbia, the largest oncological institution in the Republic of Serbia and the national center for cancer research. She spent three years in doctoral studies in Brussels, at the Jules Bordet Institute as a recipient of a TRANSBIG scholarship at the academic organization Breast International Group (BIG), supported by the European Commission (European Commission, Framework Program VII, and The European Cancer Organization, ECCO). She worked as a medical advisor for clinical and translational research in the field of breast cancer and innovative drugs within the academic organization BIG and the Breast data center.

Dr Božović-Spasojević is the founder of the academic group for breast cancer research in Serbia. And leads the research program on breast cancer in men in Serbia within the EORTC (European Organization for Research and Treatment of Cancer) organization; participates in the fertility preservation and pregnancy planning program for patients with breast cancer, within the framework of fertility preservation counseling.

She is one of the authors of the national guide for the treatment of breast cancer, as well as the author of a clinical oncology textbook for students of the Faculty of Medicine in Belgrade. She has written numerous brochures for patients being treated for malignant diseases. Dr Božović-Spasojević has participated in the leadership program within the European Association of Medical Oncologists, ESMO Leaders Generation Program 2018. She graduated from the Academy for Health Management in Serbia, Methodes doo, FranklinCovey USA in 2017. She is a member of the Central Ethics Committee of Serbia, a member of the working group for oncology at the Ministry of Health in the period from 2015 to 2020. She is also a member of the board of directors of the National Association of Medical Oncologists of Serbia, UMOS; head of the working group for the treatment of malignant diseases in young people at the European Society for Medical Oncologists (ESMO).

Oncologists

Prim. dr sci. med. Davorin Radosavljević

Ass. dr sci. med. Marijana Milović-Kovačević

Spec. dr med. Feđa Đorđević

Dr med. Miodrag Jašović

Dr sci. med. Vojislav Bogosavljević

neurosurgeon

Education:

basic studies, Faculty of Medicine, University of Belgrade
1999 master’s degree, Faculty of Medicine, University of Belgrade
2002 specialization in neurosurgery, Faculty of Medicine, University of Belgrade
2014 PhD, Faculty of Medicine, University of Belgrade

Work experience:

Neurosurgeon, Institute of Neurosurgery KCS
2012 Assistant, Faculty of Medicine in Belgrade

Publications:

Changes in the activity of antioxidant protection enzymes in the blood and tissue of patients with glioblastoma and meningioma”
Comparative analysis of antioxidative systems in malignant and benign brain tumors

Memberships:

Serbian Medical Association
Medical Chamber of Serbia

Surgeons

Ass. dr Igor Spurnić

Prof. dr Dragan Radovanović

Prof. dr Milan Savić

Dr sc. med. Stevan Jokić

Ass. dr Darko Milovanović

Dr Vladan Pošarac